Moreover, studies assessing the antiviral potency of murine IFN-α transgene therapy in mouse models of infection with influenza virus, murine cytomegalovirus, and herpes simplex virus revealed that IFN-α subtypes exerted distinct antiviral potencies in a virus-specific manner (21, –, 24). This evidence concerns the gene IFNA2 and infection.